XCR Diagnostics Inc:企業の製品パイプライン分析

◆英語タイトル:XCR Diagnostics Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME130178PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥243,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
XCR Diagnostics Inc (XCR Diagnostics) is a designer and developer of real-time PCR assays. The company’s products include brucella abortus detection assay, brucella ovis detection assay and custom real time PCR master mix. It offers services such as assay design services, assay design and confirmation services, assay consulting, custom chemical formulation, custom research and development and assay validation, radiance genotyping, and reorder and quality assurance services. XCR Diagnostics also provides sequences of primers, sequences of the fluorescent probes, oligonucleotide sequences, oligonucleotide alignment and amplification protocol. The company serves universities, clinical laboratories, and pharmaceutical companies globally. XCR Diagnostics is headquartered in Salt Lake City, Utah, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company XCR Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
XCR Diagnostics Inc Company Overview
XCR Diagnostics Inc Company Snapshot
XCR Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
XCR Diagnostics Inc – Pipeline Analysis Overview
XCR Diagnostics Inc – Key Facts
XCR Diagnostics Inc – Major Products and Services
XCR Diagnostics Inc Pipeline Products by Development Stage
XCR Diagnostics Inc Pipeline Products Overview
COVID-19 Test
COVID-19 Test Product Overview
Pyramid Portable Nucleic Acid Testing System
Pyramid Portable Nucleic Acid Testing System Product Overview
Pyramid System – BP/BPP Assay
Pyramid System – BP/BPP Assay Product Overview
Pyramid System – C. Difficile Assay
Pyramid System – C. Difficile Assay Product Overview
Pyramid System – Enterovirus/Paraechovirus Assay
Pyramid System – Enterovirus/Paraechovirus Assay Product Overview
Pyramid System – Group A Strep Assay
Pyramid System – Group A Strep Assay Product Overview
Pyramid System – Group B Strep Assay
Pyramid System – Group B Strep Assay Product Overview
Pyramid System – HSV-1/HSV-2/VZV Assay
Pyramid System – HSV-1/HSV-2/VZV Assay Product Overview
Pyramid System – Influenza A/B And RSV Assay
Pyramid System – Influenza A/B And RSV Assay Product Overview
Pyramid System – MRSA Assay
Pyramid System – MRSA Assay Product Overview
Pyramid System – Norovirus Assay
Pyramid System – Norovirus Assay Product Overview
XCR Assay – Group C Streptococcus
XCR Assay – Group C Streptococcus Product Overview
XCR Assay – Group G Streptococcus
XCR Assay – Group G Streptococcus Product Overview
XCR Diagnostics Inc – Key Competitors
XCR Diagnostics Inc – Key Employees
XCR Diagnostics Inc – Locations And Subsidiaries
Head Office
Recent Developments
XCR Diagnostics Inc, Recent Developments
Mar 05, 2020: XCR Diagnostics secures patent for identifying infectious diseases 5X faster than the standard industry test
Dec 18, 2019: XCR Diagnostics announces the appointment of J. Chuck Morrison to its board of directors
Oct 18, 2018: XCR Diagnostics names Daniel Kolk as Vice President of Clinical Development
Aug 10, 2016: Fluoresentric Names Lynda A. Merrill CEO
Apr 13, 2016: XCR Diagnostics Board Appoints Mark Powelson CEO
Oct 14, 2015: Fluoresentric Transfers XCR Portable Diagnostic System IP to XCR Dx Subsidiary
May 13, 2015: Fluoresentric to Launch XCR Dx Subsidiary
Nov 04, 2010: Fluoresentric Releases Advanced Direct-2-PCR Sample Kits For Nasal, Throat, And Cheek Swab Diagnostic Health Tests
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
XCR Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
XCR Diagnostics Inc Pipeline Products by Equipment Type
XCR Diagnostics Inc Pipeline Products by Indication
XCR Diagnostics Inc, Key Facts
XCR Diagnostics Inc, Major Products and Services
XCR Diagnostics Inc Number of Pipeline Products by Development Stage
XCR Diagnostics Inc Pipeline Products Summary by Development Stage
COVID-19 Test - Product Status
COVID-19 Test - Product Description
Pyramid Portable Nucleic Acid Testing System - Product Status
Pyramid Portable Nucleic Acid Testing System - Product Description
Pyramid System - BP/BPP Assay - Product Status
Pyramid System - BP/BPP Assay - Product Description
Pyramid System - C. Difficile Assay - Product Status
Pyramid System - C. Difficile Assay - Product Description
Pyramid System - Enterovirus/Paraechovirus Assay - Product Status
Pyramid System - Enterovirus/Paraechovirus Assay - Product Description
Pyramid System - Group A Strep Assay - Product Status
Pyramid System - Group A Strep Assay - Product Description
Pyramid System - Group B Strep Assay - Product Status
Pyramid System - Group B Strep Assay - Product Description
Pyramid System - HSV-1/HSV-2/VZV Assay - Product Status
Pyramid System - HSV-1/HSV-2/VZV Assay - Product Description
Pyramid System - Influenza A/B And RSV Assay - Product Status
Pyramid System - Influenza A/B And RSV Assay - Product Description
Pyramid System - MRSA Assay - Product Status
Pyramid System - MRSA Assay - Product Description
Pyramid System - Norovirus Assay - Product Status
Pyramid System - Norovirus Assay - Product Description
XCR Assay - Group C Streptococcus - Product Status
XCR Assay - Group C Streptococcus - Product Description
XCR Assay - Group G Streptococcus - Product Status
XCR Assay - Group G Streptococcus - Product Description
XCR Diagnostics Inc, Key Employees
Glossary

★海外企業調査レポート[XCR Diagnostics Inc:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Napp Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Napp Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Culture Landmark Investment Limited:戦略・SWOT・企業財務分析
    Culture Landmark Investment Limited - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Bush Industries Inc:企業の戦略・SWOT・財務分析
    Bush Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Bush Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Public Power Corporation SA (PPC):電力:M&Aディール及び事業提携情報
    Summary Public Power Corporation SA (PPC) is a vertically integrated electric utility. It generates and supplies electricity. The company produces energy using lignite, gas, oil, hydro, wind and solar sources. PPC owns power generation projects across the country; holds interests in lignite mines in …
  • Human Care HC AB:企業の戦略的SWOT分析
    Human Care HC AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • IndusInd Bank Ltd:戦略・SWOT・企業財務分析
    IndusInd Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary IndusInd Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Neonc Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NeOnc Technologies Inc (NTI) is an early-stage cancer biotechnology company that focuses on the development of intranasal inhalation and other non-invasive therapies for the treatment of malignant brain cancer, lung cancer and other brain cancers. The company’s product portfolio includes NEO …
  • Nippon Yusen Kabushiki Kaisha (9101)-石油・ガス分野:企業M&A・提携分析
    Summary Nippon Yusen Kabushiki Kaisha (NYK) is a logistics company transporting crude oil and allied products. The company provides ocean, land, and air transport services for the transportation of petroleum products, liquid products and dry bulk products. Its portfolio includes line trade, air carg …
  • Deutsche Telekom AG:戦略・SWOT・企業財務分析
    Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Aptinyx Inc (APTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Aptinyx Inc. (Aptinyx), formerly Enarex Inc, is a clinical-stage biopharmaceutical company that discovers and develops novel therapies for the treatment of neurological disorders. The company’s proprietary chemistry platform helps develop a pipeline of small-molecule modulators of N-methyl-D …
  • Hunter Douglas NV (HDG):企業の財務・戦略的SWOT分析
    Hunter Douglas NV (HDG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Quantum Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Quantum Pharma Ltd (Quantum Pharma), a subsidiary Clinigen Group Plc, is a manufacturer and supplier of unlicensed medicines. The company develops, manufactures, and supplies niche pharmaceutical products. It offers dermatology products, branded generics and vitamins, borderline substances, …
  • Graphic Packaging Holding Company
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Grindeks (GRD1R):製薬・医療:M&Aディール及び事業提携情報
    Summary Grindeks focuses on the research, development, manufacture and marketing of novel pharmaceuticals, generic products and active pharmaceutical ingredients (APIs). Its products are indicated for treating diseases in cardiovascular, central nervous system (CNS) and cancer therapeutic categories …
  • Carl Zeiss AG:企業の戦略的SWOT分析
    Carl Zeiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Consolidated Edison Company of New York, Inc.:発電所・企業SWOT分析
    Consolidated Edison Company of New York, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, in …
  • First Solar, Inc.:企業の戦略・SWOT・財務情報
    First Solar, Inc. - Strategy, SWOT and Corporate Finance Report Summary First Solar, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Nihon Kohden Corporation:戦略・SWOT・企業財務分析
    Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report Summary Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Alterity Therapeutics Ltd (PBT):企業の財務・戦略的SWOT分析
    Summary Alterity Therapeutics Ltd (Alterity Therapeutics) formerly known as Prana Biotechnology Ltd, is a developer of therapeutic drugs. The company is conducting research into Huntington disease, Alzheimer's disease, brain cancer and other major age-related degenerative disorders. It is developing …
  • Mirach Energy Ltd (AWO):企業の財務・戦略的SWOT分析
    Summary Mirach Energy Ltd (Mirach Energy), formerly China Petrotech Holdings Ltd is a diversified company. The company operates through its business such as property and construction and oilfield services. Its oilfield services business offers enhanced oil recovery techniques and consultancy service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆